Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
- Status
- COMPLETED
- Phase
- PHASE3
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1
Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE2
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Status
- RECRUITING
- Phase
- N/A
Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
- Status
- COMPLETED
- Phase
- NA
Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
- Status
- COMPLETED
- Phase
- PHASE2
Pathogenesis of Hematologic Malignancies
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.
- Status
- COMPLETED
- Phase
- PHASE2
Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Connect® Myeloid Disease Registry
- Status
- TERMINATED
- Phase
- N/A
Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2